Mild-to-moderate aortic and mitral regurgitation are frequently detected by echocardiogram in asymptomatic hypertensive patients. Our goal was to assess the prevalence and impact of mild-to-moderate mitral and/ or aortic regurgitation on left ventricular (LV) structure and function in patients with hypertension and LV hypertrophy (LVH). Hypertensive patients with ECG LVH enrolled in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) echocardiography substudy were evaluated. Among 939 patients with needed LV measurements and Doppler data, 242 had mild (1 þ ) valvular regurgitation, and 51 patients had moderate (2 þ or 3 þ ) regurgitation of one or both valves. In analyses adjusting for gender, patients with mild mitral and/or aortic regurgitation had larger LV internal dimensions (5.25 vs 5.33 cm, Po0.05), higher LV mass indexed for body surface area (122 vs 125 g/m 2 , Po0.05) or height 2.7 (55.4 vs 57.3, Po0.05), and larger left atrial diameter. Patients with moderate regurgitation of one or both valves had larger LV chambers (5.25 vs 5.9 cm, Po0.001), greater mean LV mass (232 vs 248 g, Po0.001) and LV mass indexed for body surface area or height 2.7 , and higher Doppler stroke volume. Patients with moderate valvular regurgitation also had a higher prevalence of LVH due to an increased prevalence of eccentric LVH. There were no differences among groups defined by the presence and severity of valvular regurgitation in cardiac output, total peripheral resistance, or pulse pressure/stroke volume, indicating that the observed inter-group differences in LV geometry were not due to differences in the haemodynamic severity of hypertension. Hypertensive patients with mild-to-moderate mitral or aortic valvular insufficiency have additional LV structural and functional changes that may affect prognosis.
Mild-to-moderate aortic and mitral regurgitation are frequently detected by echocardiogram in asymptomatic hypertensive patients. Our goal was to assess the prevalence and impact of mild-to-moderate mitral and/ or aortic regurgitation on left ventricular (LV) structure and function in patients with hypertension and LV hypertrophy (LVH). Hypertensive patients with ECG LVH enrolled in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) echocardiography substudy were evaluated. Among 939 patients with needed LV measurements and Doppler data, 242 had mild (1 þ ) valvular regurgitation, and 51 patients had moderate (2 þ or 3 þ ) regurgitation of one or both valves. In analyses adjusting for gender, patients with mild mitral and/or aortic regurgitation had larger LV internal dimensions (5.25 vs 5.33 cm, Po0.05), higher LV mass indexed for body surface area (122 vs 125 g/m 2 , Po0.05) or height 2.7 (55.4 vs 57.3, Po0.05), and larger left atrial diameter. Patients with moderate regurgitation of one or both valves had larger LV chambers (5.25 vs 5.9 cm, Po0.001), greater mean LV mass (232 vs 248 g, Po0.001) and LV mass indexed for body surface area or height 2.7 , and higher Doppler stroke volume. Patients with moderate valvular regurgitation also had a higher prevalence of LVH due to an increased prevalence of eccentric LVH. There were no differences among groups defined by the presence and severity of valvular regurgitation in cardiac output, total peripheral resisIntroduction Left ventricular hypertrophy (LVH) is an adaptive process that helps maintain cardiac performance in the setting of increased afterload. Although this process is beneficial initially, at more advanced stages LVH becomes detrimental and leads to increased rates of cardiovascular events. Thus, established LVH is known to be an independent predictor of stroke, myocardial infarction, other vascular complications, cardiac arrhythmia, sudden death, and heart failure. [1] [2] [3] Mild-to-moderate aortic and mitral regurgitation are frequently detected on routine echocardiograms in asymptomatic hypertensive patients, although their prevalences have not been determined. Studies in population-based samples of predominately normotensive adults have shown associations of mildto-moderate mitral and aortic regurgitation with greater left ventricle (LV) chamber size and mass. [4] [5] [6] However, the impact of mild-to-moderate valvular regurgitation on LV geometry and function in hypertensive patients is unknown. Controlled studies have identified an association between uncontrolled hypertension and mild aortic root enlargement. 7 Other studies have suggested an association between higher arterial pressure and greater severity of mitral regurgitation in patients with mitral valve prolapse. 8, 9 The present study was therefore undertaken to assess the prevalences of mild-to-moderate mitral or aortic regurgitation in patients with hypertension and electrocardiographic LVH, and to determine the impact of these valvular lesions on LV structure and function.
Methods

Subjects
Patients with stage I-III hypertension enrolled in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study 10, 11 were evaluated. Of the 9193 patients enrolled in LIFE, 410% participated in the echocardiography substudy. As part of the baseline evaluation, these patients underwent 2-dimensional, M-mode, and Doppler echocardiography. All patients gave written informed consent under protocols approved by institutional review boards at each participating institution. Prior to enrollment, all patients had a screening electrocardiogram that showed LVH by either sex-adjusted Cornell voltage (SV 3 þ RaVL (with 6 mm gender adjustment in women) Â duration X 2440 mm Â ms) or Sokolow-Lyon voltage (SV 1 þ RV 5 ÀV 6 4 38 mm). 10 Inclusion criteria for the LIFE study included absence of severe LV dysfunction, heart failure or other conditions requiring therapy with angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, or beta blockers; angina; myocardial infarction or stroke in the past 6 months; or blood pressure that rose to 4200 mmHg systolic or 115 mmHg diastolic during 2 weeks of placebo treatment.
Echocardiographic measurements and performance
Echocardiographic procedures for this study were based on procedures employed in previous studies 12, 13 and have been described previously. 14, 15 Colour flow Doppler recordings from parasternal and apical windows were used to search for aortic and mitral regurgitation. 16 Aortic regurgitation (AR) was identified based on the extent of diastolic turbulent flow in the LV, indicated by a variance signal, with mild (1 þ ) AR identified by a jet occupying o20% of aortic annular diameter at its origin and extending less than half-way to the tip of the anterior mitral leaflet; mild-moderate (2 þ ) AR by jets filling 20-40% of annular diameter extending up to the tip of the anterior mitral leaflet; moderately severe (3 þ ) AR by jets occupying 40-60% of annular diameter extending to or slightly beyond the tip of the anterior mitral leaflet; and severe (4 þ ) AR by jets occupying 460% of annular diameter extending to the posterior wall of the LV or more than half-way to the LV apex. 5, 16 For jets oriented perpendicular to the aortic anular plane, rather than crossing the valve's LV surface, priority was given to jet width criteria. 5, 16 Mitral regurgitation (MR) was assessed by colour Doppler using a modification of the method developed by Miyatake et al 17 with pulsed-wave Doppler. The severity of MR was graded on a four-point scale on the basis of the farthest distance reached from the mitral orifice: p1.5 cm ¼ mild (1 þ ) MR, 1.5-3.0 cm ¼ moderate (2 þ ) MR, 3.0-4.5 cm ¼ modemoderately severe (3 þ ) MR, and 44.5 cm ¼ severe (4 þ ) MR. 6 When centrally oriented MR jets were unusually narrow, 2 þ to 4 þ MR grades were reduced by one grade, and 1 þ to 3 þ MR grades were increased by one grade when unusually wide jets had disproportionate areas to their length or when eccentric jets hugged the left atrial wall. 16 
Calculation of derived variables and LVH
End-diastolic LV internal dimension and interventricular and posterior wall thicknesses were used to calculate LV mass using a formula that has been shown to yield values closely related (r ¼ 0.90) to necropsy LV weight, 18 and that had good inter-study reproducibility (RHO ¼ 0.93) in a separate study. 19 Relative wall thickness was calculated as diastolic posterior wall thickness/LV internal radius. LVH was identified when LV mass index exceeded 116 g/ m 2 in men or 104 g/m 2 in women. 15 Increased relative wall thickness was present when 40.43, the 97.5th percentile in normal subjects. 20 LV geometry was defined using LV mass index and relative wall thickness as previously described. 21 LV systolic performance LV ejection fraction was calculated by Teichholz' formula. 22 Endocardial fractional shortening was calculated from LV internal dimension in diastole and systole. 23 Values o27%, representing the 2.5th percentile in normal subjects, 24 identified depressed LV systolic chamber function. In individuals with increased relative wall thickness 25 or LV dilatation, 26 endocardial shortening is not representative of that at the LV midwall where mean LV end-systolic wall stress is applied. Therefore, we used the relation between midwall shortening and midwall circumferential end-systolic stress measured at the level of the LV minor axis. 25, 26 The location in the LV wall at end systole of the surface between the inner and outer halves of the myocardium at end diastole can be identified by assuming the ratio of inner/outer myocardial shell volumes remains constant through the cardiac cycle. 26, 27 Midwall shortening o14%, the 2.5th percentile of values in the normal subjects, 24 identified depressed LV midwall shortening. End-systolic stress, as the primary measure of myocardial afterload, was estimated at the midwall from M-mode tracings, using a cylindrical model described by Gaasch et al. 26, 27 End-systolic stress 27 of 174 kdyn/cm 2 corresponds to the 97.5th percentile in normals; 24 accordingly, higher values identified increased myocardial afterload. Stress-corrected endocardial fractional shortening and midwall shortening are derived from observed/predicted shortening. Stress-corrected fractional shortening o94% and stress-corrected midwall shortening o83% correspond to 2.5th percentiles of normal values 24 and were considered indicative of low LV chamber and myocardial function.
LV diastolic function
LV diastolic filling was evaluated by classifying patients' mitral valve flow pattern according to the ratio of E-and A-wave velocities of flow between the mitral tips and in the mitral annulus, the deceleration time of early diastolic transmitral blood flow, and the isovolumic relaxation time (IVRT). Ageappropriate normal limits (5th or 95th percentiles) in individuals 60 years or older who are free of hypertension, diabetes, obesity, clinically evident coronary heart disease, and heart failure are IVRT o105 ms and mitral annulus E/A ratio o0.6.
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Deceleration time o150 ms was regarded as short, 31 and over 250 ms was considered prolonged. 32 Abnormal diastolic filling patterns were classified by a modification of the approach of Appleton et al; 33 abnormal relaxation was identified by prolonged IVRT (4105 ms) and deceleration time (4250 ms) as well as reduced mitral annulus E/A ratio (o0.6); restrictive pattern was identified by short or normal IVRT (o105 ms), reduced deceleration time (o150 ms), and E/A ratio 41.5; ''pseudonormal'' pattern was recognized by the combination of prolonged IVRT (4105 ms) with normal deceleration time and E/A ratio; and LV filling was considered normal when IVRT was o105 ms, deceleration time between 150 and 250 ms, and E/A ratio between 0.6 and 1.5.
Statistics
SPSS 11.0. software (SPSS, Inc., Chicago, IL, USA) was used for statistical analyses. Results are mean7standard deviation or frequencies expressed as percentages. Differences in continuous variables between two groups were assessed by Student's t-test; comparison among multiple groups was performed by ANOVA with the Sheffé post hoc test. Univariate relations between variables were assessed as partial correlations, adjusting for the known impact of gender. Independent correlates of continuous LV measures were identified by multiple linear regression analysis using an enter procedure with assessment of collinearity diagnostics. A twotailed P-value o0.05 was considered to be statistically significant.
Results
Patient clinical characteristics
As previously reported, 15 the 960 patients in the LIFE echocardiography substudy closely resembled the entire LIFE study population with regard to baseline blood pressure, heart rate, body build, and prevalences of cardiovascular conditions and diabetes, but included higher proportions of male and black patients. Of 939 patients with necessary LV measurements and Doppler data for inclusion in the present analysis, 646 (68.8%) had no mitral or aortic regurgitation. A total of 242 (25.8%) patients had mild (1 þ ) valvular regurgitation, including 146 (15.2%) with 1 þ MR alone, 53 (5.6%) with 1 þ AR alone, and 45 (4.8%) with mild regurgitation of both valves. In all, 51% patients (5.4%) had moderate (2 þ or 3 þ ) valvular regurgitation, including 12 (1.3%) with moderate MR alone, 17 (1.8%) with moderate AR alone, and 22 (2.3%) with moderate regurgitation of both valves. Baseline clinical characteristics of the patient groups are given in Table 1 .
Patients with mild, and especially with moderate, valvular regurgitation were more likely to be women than the patients without valvular regurgitation. Body weight, body mass index, and diastolic blood pressure tended to be lower and pulse pressure to be higher in patients with MR/AR (Table 1) ; however, these differences did not attain statistical significance in analyses that adjusted for gender. Heart rate was modestly but significantly lower, and the prevalence of prior myocardial infarction higher, in patients with moderate aortic and/or mitral regurgitation. Table 2 presents LV geometric and haemodynamic characteristics of patients with no valvular regurgitation and those with mild or moderate valvular regurgitation. In analyses that adjusted for gender, patients with mild mitral and/or aortic regurgitation had larger LV internal dimensions, higher LV mass indexed for either body surface area or height 2.7 , and larger left atrial diameters. In similar analyses, patients with moderate regurgitation of one or both valves had larger LV chambers, greater mean LV mass in absolute terms, as well as after indexing for body surface area or height 2.7 , and higher Doppler stroke volume. The patients with moderate valvular regurgitation also had a higher prevalence of LVH due to an increased prevalence of eccentric LVH. However, there was no significant difference in RWT among groups. There was no difference among groups defined by the presence and severity of valvular regurgitation in cardiac output, total per-ipheral resistance, or pulse pressure/stroke volume, indicating that the observed intergroup differences in LV geometry were not due to differences in the haemodynamic severity of hypertension.
LV geometry and haemodynamics
LV functional characteristics
Measures of LV systolic and diastolic function are depicted in Table 3 . In analyses that adjusted for gender, patients with moderate valvular regurgitation had significantly higher circumferential endsystolic wall stress (CESS, a measure of myocardial afterload) and lower CESS/ESVI (a measure of LV chamber contractility) when compared to patients without valvular regurgitation. Trends towards longer isovolumic relaxation time and deceleration time of early diastolic transmitral flow, indices of impaired early diastolic LV relaxation, did not attain statistical significance.
Discussion
This study, for the first time, provides information on the impact of mild and moderate MR and/or AR in patients with LVH and moderate hypertension by evaluating echocardiographic indices of LV structure and function in patients participating in the LIFE echocardiography substudy. In accord with data from national hospital discharge surveys, valvular regurgitation was positively associated with female gender. After adjustment for the effect of gender, the present study showed that patients with mild, and especially with moderate AR and/or MR, had larger LV cavity dimensions and greater LV mass than the patients without valvular regurgitation. Of particular importance, the patients with moderate AR and/or MR had a higher prevalence of LVH due to an increased frequency of eccentric LVH, compared to similarly hypertensive patients. These findings extend to the high-risk population of hypertensive patients with LVH the observation that mitral and/or aortic regurgitation was associated with greater LV size and hypertrophy previously reported in population-based samples of predominantly normotensive adults. [4] [5] [6] [7] In addition, the group with moderate valvular regurgitation also had higher LV myocardial afterload, as measured by circumferential end-systolic stress, and lower LV chamber contractility, as manifested by a lower end-systolic stress/endsystolic volume index ratio, compared to equally hypertensive patients without valvular regurgitation. Previous studies have identified increased LV myocardial afterload and lower LV chamber contractility as predictors of the development and progression of heart failure, ventricular arrhythmias, and sudden death.
The present study documents a significant and hitherto largely unappreciated interaction between the adverse effects of hypertension and of concomitant valvular regurgitation on LV geometry and function. Patients with mild, and to an even greater extent moderate, mitral and/or aortic regurgitation had greater LV enlargement, hypertrophy, and afterload and chamber dysfunction, all of which are known to be associated with an adverse prognosis. Taken together with studies documenting the strong predictive value of LVH for cardiovascular events and all-cause mortality in hypertensive patients, these findings suggest that hypertensive patients with moderate, or even mild, concomitant valvular regurgitation are a group of patients at especially high cardiovascular risk. Further research is needed to verify this, and to determine whether changes in the severity of valvular regurgitation during antihypertensive treatment influence the rates of subsequent cardiovascular events and of death.
We provide evidence that in the future, mild (1 þ ), and especially moderate, valvular regurgitation should not be ignored as a potential cause of LVH and of reduced LV chamber function in hypertensive patients. Follow-up data from the LIFE study will provide additional prognostic information and help define therapeutic effects in hypertensive patients with mild-to-moderate valvular regurgitation, but also possibly provide another reason for the beneficial effects of angiotensin receptor blockade on cardiovascular morbidity and mortality independent of blood pressure reduction.
